- Home
- INM vs OBLG Comparison
INM vs OBLG Comparison
Compare INM & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- OBLG
- Stock Information
- Founded
- INM 1981
- OBLG 2000
- Country
- INM Canada
- OBLG United States
- Employees
- INM N/A
- OBLG N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- OBLG Computer Software: Programming Data Processing
- Sector
- INM Health Care
- OBLG Technology
- Exchange
- INM Nasdaq
- OBLG Nasdaq
- Market Cap
- INM 5.0M
- OBLG 5.5M
- IPO Year
- INM N/A
- OBLG N/A
- Fundamental
- Price
- INM $2.07
- OBLG $2.97
- Analyst Decision
- INM
- OBLG
- Analyst Count
- INM 0
- OBLG 0
- Target Price
- INM N/A
- OBLG N/A
- AVG Volume (30 Days)
- INM 116.2K
- OBLG 88.1K
- Earning Date
- INM 11-13-2025
- OBLG 11-07-2025
- Dividend Yield
- INM N/A
- OBLG N/A
- EPS Growth
- INM N/A
- OBLG N/A
- EPS
- INM N/A
- OBLG N/A
- Revenue
- INM $4,942,633.00
- OBLG $2,355,000.00
- Revenue This Year
- INM N/A
- OBLG N/A
- Revenue Next Year
- INM N/A
- OBLG N/A
- P/E Ratio
- INM N/A
- OBLG N/A
- Revenue Growth
- INM 7.50
- OBLG N/A
- 52 Week Low
- INM $1.72
- OBLG $1.91
- 52 Week High
- INM $8.27
- OBLG $5.50
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- OBLG 53.11
- Support Level
- INM $2.04
- OBLG $2.71
- Resistance Level
- INM $2.26
- OBLG $3.15
- Average True Range (ATR)
- INM 0.14
- OBLG 0.30
- MACD
- INM -0.01
- OBLG 0.05
- Stochastic Oscillator
- INM 10.44
- OBLG 76.32
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About OBLG Oblong Inc.
Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.